CLNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
COLGATE PALMOLIVE CO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$93.39−0.72 (-0.77%)
Close on Oct 19, 2026
- Market cap
- $74.88B
- P/E (TTM)
- 37.1
- Dividend yield
- 2.23%
COLGATE PALMOLIVE CO revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral, Personal and Home Care | $4.17B | $4.13B | $4.03B | $3.99B | $3.95B | $3.79B | $3.80B | $3.91B | $3.94B | $3.96B | $3.84B | $3.86B | 77.7% | +5.4% |
| Hill's Pet Nutrition | $1.20B | $1.19B | – | – | $1.16B | $1.12B | – | – | – | – | – | – | 22.3% | +3.3% |
| Pet Nutrition | – | – | $1.20B | $1.14B | $1.16B | $1.12B | $1.14B | $1.13B | $1.11B | $1.10B | $1.12B | $1.06B | – | – |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral, Personal and Home Care | $1.08B | $1.03B | $998.00M | $992.00M | $997.00M | $971.00M | $969.00M | $1.02B | $1.06B | $1.04B | $1.01B | $1.02B | +8.5% |
| Hill's Pet Nutrition | $269.00M | $280.00M | – | – | $264.00M | $258.00M | – | – | – | – | – | – | +1.9% |
| Pet Nutrition | – | – | $286.00M | $255.00M | $264.00M | $258.00M | $274.00M | $258.00M | $235.00M | $199.00M | $231.00M | $201.00M | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Colgate Palmolive's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.